Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | Ratio IC50 | = | 54 | 20421396 | |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 2000 | nM | 12828478 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 8000 | nM | 20450170 |
NPT2679 | Cell Line | LLC-MK2 | Macaca mulatta | IC50 | = | 26000 | nM | 19637889 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC472735 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC472735 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.6386 | Remote Similarity | NPD1426 | Clinical (unspecified phase) |
0.6173 | Remote Similarity | NPD1144 | Phase 2 |
0.6081 | Remote Similarity | NPD8042 | Phase 2 |
0.6081 | Remote Similarity | NPD8043 | Phase 2 |
0.5897 | Remote Similarity | NPD1097 | Approved |
0.5897 | Remote Similarity | NPD1098 | Approved |
0.5714 | Remote Similarity | NPD9642 | Approved |
0.5682 | Remote Similarity | NPD543 | Clinical (unspecified phase) |
PubChem CID   | |
ChEMBL   | CHEMBL3581919 |
ZINC   |
Molecular Weight:   | 261.22 |
ALogP:   | -2.7464 |
MLogP:   | 2.89 |
XLogP:   | 5.17 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 39.45 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 19 |